Testing on additional glioblastoma cell lines for migration to HGF and FBS, comparing levels of HGF’s receptor, Met, among them, comparing MEM (provided a positive K+ gradient) versus Dulbecco’s PBS (no K+ gradient), and more extensive testing of chemokinetic effects, are reported here. The gene discussed is HGF; the disease is glioblastoma.